BRD2 and adenoma: In silico analysis of BeadChip450K methylation data of Luo et al. [24] (41 NAT/normal, 42 adenoma and 64 CRC samples) revealed highly significant hypomethylation of cg00863099 CpG site within LINC00152 promoter in CRC samples compared to N/NAT groups (p < 0.0001).